Philip James Wealth Mangement LLC lifted its position in The Procter & Gamble Company (NYSE:PG – Free Report) by 107.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 5,206 shares of the company’s stock after buying an additional 2,700 shares during the period. Philip James Wealth Mangement LLC’s holdings in Procter & Gamble were worth $902,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. China Universal Asset Management Co. Ltd. lifted its position in Procter & Gamble by 5.5% during the first quarter. China Universal Asset Management Co. Ltd. now owns 32,001 shares of the company’s stock valued at $5,192,000 after purchasing an additional 1,657 shares during the period. Quent Capital LLC lifted its position in Procter & Gamble by 2.0% during the first quarter. Quent Capital LLC now owns 10,684 shares of the company’s stock valued at $1,733,000 after purchasing an additional 206 shares during the period. Commonwealth Retirement Investments LLC lifted its position in Procter & Gamble by 1.9% during the first quarter. Commonwealth Retirement Investments LLC now owns 27,099 shares of the company’s stock valued at $4,397,000 after purchasing an additional 496 shares during the period. DAVENPORT & Co LLC lifted its position in Procter & Gamble by 2.0% during the first quarter. DAVENPORT & Co LLC now owns 152,378 shares of the company’s stock valued at $24,723,000 after purchasing an additional 2,996 shares during the period. Finally, Keener Financial Planning LLC lifted its position in Procter & Gamble by 12.0% during the first quarter. Keener Financial Planning LLC now owns 661 shares of the company’s stock valued at $108,000 after purchasing an additional 71 shares during the period. Institutional investors own 65.77% of the company’s stock.
Analyst Ratings Changes
PG has been the topic of a number of research analyst reports. Morgan Stanley increased their price objective on shares of Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a research report on Monday, October 21st. Deutsche Bank Aktiengesellschaft increased their price objective on shares of Procter & Gamble from $171.00 to $176.00 and gave the company a “buy” rating in a research report on Wednesday, July 17th. Jefferies Financial Group cut shares of Procter & Gamble from a “buy” rating to a “hold” rating and reduced their target price for the company from $182.00 to $175.00 in a report on Wednesday, July 24th. Stifel Nicolaus upped their target price on shares of Procter & Gamble from $157.00 to $161.00 and gave the company a “hold” rating in a report on Monday, July 22nd. Finally, Wolfe Research raised shares of Procter & Gamble to a “strong-buy” rating in a report on Friday, August 23rd. Nine equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $177.00.
Procter & Gamble Price Performance
Shares of NYSE:PG traded up $2.06 during midday trading on Friday, reaching $165.47. 974,631 shares of the company were exchanged, compared to its average volume of 6,635,311. The company has a current ratio of 0.75, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50. The business’s fifty day moving average is $171.29 and its two-hundred day moving average is $168.13. The Procter & Gamble Company has a one year low of $142.50 and a one year high of $177.94. The stock has a market cap of $389.69 billion, a PE ratio of 28.17, a price-to-earnings-growth ratio of 3.57 and a beta of 0.42.
Procter & Gamble (NYSE:PG – Get Free Report) last issued its earnings results on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, topping analysts’ consensus estimates of $1.90 by $0.03. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The firm had revenue of $21.74 billion during the quarter, compared to analyst estimates of $21.99 billion. During the same quarter in the prior year, the business earned $1.83 earnings per share. Procter & Gamble’s revenue for the quarter was down .6% on a year-over-year basis. As a group, analysts predict that The Procter & Gamble Company will post 6.94 earnings per share for the current year.
Procter & Gamble Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be given a dividend of $1.0065 per share. The ex-dividend date is Friday, October 18th. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.43%. Procter & Gamble’s dividend payout ratio is 69.48%.
Insider Buying and Selling at Procter & Gamble
In other Procter & Gamble news, insider Susan Street Whaley sold 450 shares of the stock in a transaction on Tuesday, August 20th. The shares were sold at an average price of $169.22, for a total transaction of $76,149.00. Following the completion of the transaction, the insider now owns 13,072 shares in the company, valued at $2,212,043.84. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In other Procter & Gamble news, insider Susan Street Whaley sold 450 shares of the stock in a transaction on Tuesday, August 20th. The shares were sold at an average price of $169.22, for a total transaction of $76,149.00. Following the completion of the transaction, the insider now owns 13,072 shares in the company, valued at $2,212,043.84. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Jon R. Moeller sold 37,240 shares of the firm’s stock in a transaction dated Wednesday, August 28th. The stock was sold at an average price of $168.89, for a total transaction of $6,289,463.60. Following the completion of the sale, the chief executive officer now owns 263,537 shares of the company’s stock, valued at $44,508,763.93. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 313,597 shares of company stock worth $53,268,499 over the last 90 days. 0.18% of the stock is owned by insiders.
Procter & Gamble Profile
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
See Also
- Five stocks we like better than Procter & Gamble
- 3 Healthcare Dividend Stocks to Buy
- The Top 5 Performing S&P 500 Stocks YTD in 2024
- Russell 2000 Index, How Investors Use it For Profitable Trading
- L3Harris: Positioned for Gains With Trump’s Defense Policies
- What Are Growth Stocks and Investing in Them
- Is First Solar’s Earnings Drop a Golden Buying Opportunity?
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.